Effects of Polyol Pathway Hyperactivity on Protein Kinase C Activity, Nociceptive Peptide Expression, and Neuronal Structure in Dorsal Root Ganglia in Diabetic Mice

Abstract

We explored the specific impact of polyol pathway hyperactivity on dorsal root ganglia (DRG) using transgenic mice that overexpress human aldose reductase because DRG changes are crucial for the development of diabetic sensory neuropathy. Littermate mice served as controls. Half of the animals were made diabetic by streptozotocin injection and followed for 12 weeks. After diabetes onset, diabetic transgenic mice showed a significant elevation of pain sensation threshold after transient decrease and marked slowing of motor and sensory nerve conduction at the end of the study, while these changes were modest in diabetic littermate mice. Protein kinase C (PKC) activities were markedly reduced in diabetic transgenic mice, and the changes were associated with reduced expression of membrane PKC-␣ isoform that was translocated to cytosol. Membrane PKC-␤II isoform expression was contrariwise increased. Calcitonin gene-related peptide-and substance P-positive neurons were reduced in diabetic transgenic mice and less severely so in diabetic littermate mice. Morphometric analysis disclosed neuronal atrophy only in diabetic transgenic mice. Treatment with an aldose reductase inhibitor (fidarestat 4 mg ⅐ kg -1 ⅐ day -1, orally) corrected all of the changes detected in diabetic transgenic mice. These findings underscore the pathogenic role of aldose reductase in diabetic sensory neuropathy through the altered cellular signaling and peptide expressions in DRG neurons. Diabetes 53:3239 -3247, 2004 P olyol pathway hyperactivity has been extensively studied for the mechanisms of diabetic neuropathy, where aldose reductase is a key regulating enzyme (1,2). In animal models, diabetes-induced peripheral nerve conduction deficits, neurometabolic imbalances, altered nerve blood flow, and morphologic abnormalities are prevented by structurally diverse aldose reductase inhibitors (ARIs) (3-5). Past clinical trials of ARIs were not, however, convincingly successful (6,7), and specific effects of polyol pathway hyperactivity on the clinical and structural aspects of diabetic sensory neuropathy is yet to be clear (8,9). The development of a transgenic animal model provides an ideal tool to identify the specific role of single molecules in disease mechanisms. We have established a strain of transgenic mice that overexpress human aldose reductase (10 -12). In this model, we confirmed that polyol pathway hyperactivity was indeed related to the severity of motor nerve conduction delay and nerve fiber atrophy. More recently, a new transgenic model that overexpresses aldose reductase, specifically in Schwann cells by use of myelin protein Po promoter, has enabled researchers to address more precise mechanisms of polyol pathway in the development of neuropathy in diabetes (13). Nevertheless, from these studies, it was not shown which measures were comparable with those found in human diabetic neuropathy, and it still remains obscure what could be the most appropriate target for the intervention with a potent and specific inhibitor for human aldos...

The β2 adrenergic receptor regulates morphine tolerance and physical dependence

“…A larger percentage of DRG neurons stained positively for SP as compared with CGRP, and SP staining neurons nearly always co-expressed β2-AR. The DRG peptide staining patterns were similar to other recent reports [41,45].…”

Continuous -Opioid Receptor Activation Reduces Neuronal Voltage-Gated Sodium Channel (NaV1.7) Levels through Activation of Protein Kinase C in Painful Diabetic Neuropathy

“…PKC␤ activity is increased in the DRG of diabetic compared with control mice (Uehara et al, 2004), phorbol esters that activate PKC increase nociceptive responsiveness in inflammatory pain (Coderre, 1992) and enhance thermal hyperalgesia in diabetic rats (Ohsawa and Kamei, 1999), and inhibition of PKC decreases hyperalgesia in STZ diabetic rats (Ahlgren and Levine, 1994), attenuates thermal hyperalgesia induced by partial sciatic nerve ligation, and attenuates opiateinduced antinociception in diabetic mice (Ohsawa and Kamei, 1997). Previous studies have suggested that PKC activation may modulate the electrophysiologic properties of tetrodotoxin (TTX)-sensitive and TTX-resistant voltage-gated sodium channels (Dascal and Lotan, 1991;Numann et al, 1991;Thio and Sontheimer, 1993), but this is the first report to demonstrate PKC-mediated regulation of voltage-gated sodium channel protein levels in primary sensory neurons in vitro and in vivo.…”

Aldose Reductase Pathway Inhibition Improved Vascular and C-Fiber Functions, Allowing for Pressure-Induced Vasodilation Restoration During Severe Diabetic Neuropathy

“…In the current study, 8 weeks of diabetes altered the unmyelinated Cfibers response, as seen by an increase of tail withdrawal latency, demonstrating hypoalgesia. Uehara et al (35) revealed that the pain sensation in diabetic mice was initially hyperalgesic, followed by late hypoesthesia in the presence of severe neuropathy. In diabetic patients, thermal hypoalgesia is associated with degenerative neuropathy, which includes the loss of epidermal C-fiber terminals (33,36).…”